Seth Kuranz, PhD

Inovalon, Bowie, MD, United States

Disclosure(s): Inovalon: Employee of Inovalon, a consulting company that received funding from GSK to conduct this study.

Poster(s):

• (P-779) Antibiotic Treatment Selection and Failure by Race and Ethnicity for Uncomplicated Urinary Tract Infection in US Female Patients
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-787) Descriptive Analysis of Treatment Failure in Uncomplicated Urinary Tract Infection Among US Female Patients with Diabetes: Stratified by Level of Diabetes Control
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-788) Urinary Tract Infection Treatment Failure Differences in a 1:1 Matched Cohort of US Female Patients with and without Diabetes
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-2073) Examining the Impact of Social Determinants of Health on Treatment Failure in US Female Patients Treated For Uncomplicated Urinary Tract Infection
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET